OncoSystem Directory
Explore organizations in the global Oncology ecosystem
724 organization(s) found
Noujoum (Morocco)
Member organisation within a global childhood-cancer NGO network.
Casablanca, Morocco
WebsiteNurix Therapeutics
Nurix is writing medicine's next chapter using targeted protein degradation as a new script to outmatch disease.
TPD for Oncology and Autoimmune Diseases Brisbane, CA, United States WebsiteObi Pharma
OBI Pharma, Inc. is a global clinical stage oncology company that is headquartered in Taiwan, with subsidiaries in the USA and Australia. OBI focuses on innovative R&D for cancer therapies and aims to develop �first-in-class� and �best-in-class� ground-breaking drugs. It aspires to market these drugs worldwide with a �Made in Taiwan� branding and to provide new treatment options for patients with unmet medical needs.
ADCs (including bispecific, dual-payload ADCs) for Oncology Nangang District, Taipei City, Taiwan
WebsiteObservatorio del Cáncer - Chile
In Spanish: "El Observatorio del Cáncer es una fundación sin fines de lucro constituida formalmente el 8 de abril de 2019 inspirada en contribuir con acciones de educación, prevención y sensibilización sobre el cáncer. Nuestro objetivo es aportar a la causa del cáncer proporcionando información seria y confiable. Asimismo, queremos promover diálogos y acciones, ser un puente entre la investigación, la comunidad médica, los pacientes y la sociedad civil para generar conciencia y acción frente a esta enfermedad que afecta a miles de personas cada año."
Santiago, Chile WebsiteOCI Foundation (OCI Foundation International)
Implements anti-cancer health initiatives including the “Arm Our Youths Anti-Cancer Health Initiative” focusing on breast and cervical cancer among youths and school populations.
Awka, Nigeria WebsiteOCRA (Ovarian Cancer Research Alliance)
Ovarian Cancer Research Alliance is dedicated to curing ovarian cancer while improving treatments by advancing innovative science, promoting preventive measures, and advocating for, educating and supporting anyone affected by gynecologic cancers to ensure the best possible care and outcomes.
WebsiteOeGHO (Austrian Society of Hematology and Medical Oncology)
In German: "Im Interesse von Patient*innen und Angehörigen will die Osterreichische Gesellschaft fur Hamatologie and Medizinische Onkologie (OeGHO) die Information von Betroffenen verbessern und die Betreuung von Patient*innen mit Krebs- und Bluterkrankungen von der Prävention über die Früherkennung und Diagnose bis hin zur Behandlung und Nachsorge optimieren. Als Fachgesellschaft ... … will die OeGHO inbesondere: · die persönlichen Kontakte unter den Mitgliedern und die Beziehungen zu den entsprechenden ausländischen Gesellschaften fördern · die Interessen der in diesem Fachgebiet tätigen Ärzt*innen und Wissenschaftler*innen in Österreich vertreten."
WebsiteOhio State University / The James Comprehensive Cancer Cener
Columbus, United States WebsiteOlivia Newton-John Cancer Research Institute
We are a leading independent medical research institute, dedicated to discovering and translating innovative cancer treatments and diagnostics that improve outcomes for all people affected by cancer. The Olivia Newton-John Cancer Research Institute (ONJCRI) brings together world-class researchers, clinicians, and research support professionals in a uniquely integrated environment.
WebsiteONCO AURA
In French: "ONCO AURA est une association loi 1901 à but non lucratif, identifiée sous le n° SIRET 18693010300020. Il a pour principal financeur l’État, par l’intermédiaire de l’Agence Régionale de Santé Auvergne-Rhône-Alpes."
WebsiteOncolytics Biotech
Advancing a Transformative Double-Stranded RNA Immunotherapy Platform for Gastrointestinal Tumors
Oncolytic viral immunotherapy (pelareorep) Calgary, AB, Canada WebsiteOncomamás
In Spanish: "Nuestros Objetivos: · Lograr equidad e igualdad en cáncer infantil. · Contribuir a tener mejores tratamientos y menores impactos en la calidad de vida. · Brindar acompañamiento y orientar a familias en tratamientos de cáncer infantil en el tratamiento de sus hijos. · Realizar seguimientos y mejoras al Seguro de acompañamiento para niños y niñas, y acompañamiento legislativo a su Reforma de Ley. · Promover el uso del Seguro SANNA a las familias oncológicas para su uso desde la fase de sospecha. (Ley SANNA) · Ampliar la edad de la cobertura de tratamientos de cáncer infantil de acuerdo a las recomendaciones de la OMS hasta los 19 años. · Promover la cobertura de nuevas drogas y nuevas terapias que son utilizadas como referencia a nivel mundial. · Promover el tratamiento oportuno y las condiciones que aseguren el Trasplante de células madre a cada niño, niña y adolescente que reciban la indicación. Lograr equidad e igualdad en cáncer infantil. · Contribuir a tener mejores tratamientos y menores impactos en la calidad de vida. · Brindar acompañamiento y orientar a familias en tratamientos de cáncer infantil en el tratamiento de sus hijos. · Realizar seguimientos y mejoras al Seguro de acompañamiento para niños y niñas, y acompañamiento legislativo a su Reforma de Ley. · Promover el uso del Seguro SANNA a las familias oncológicas para su uso desde la fase de sospecha. (Ley SANNA) · Ampliar la edad de la cobertura de tratamientos de cáncer infantil de acuerdo a las recomendaciones de la OMS hasta los 19 años. · Promover la cobertura de nuevas drogas y nuevas terapias que son utilizadas como referencia a nivel mundial. · Promover el tratamiento oportuno y las condiciones que aseguren el Trasplante de células madre a cada niño, niña y adolescente que reciban la indicación."
Santiago, Chile WebsiteONCOPL (Onco Pays de Loire)
In French: "ONCOPL est le dispositif régional spécifique du cancer des Pays de la Loire, il fédère les acteurs de la cancérologie : professionnels, établissements, acteurs institutionnels, usagers, personnes morales et physiques de statut public, privé et associatif. Il n’est pas un réseau de prise en charge des patients. Sa finalité est de garantir un accès égal à des soins de qualité quels que soient le lieu et la structure de prise en charge. Il apporte appui et méthodologie aux professionnels dans la réalisation de projets visant à améliorer le suivi des patients atteints de cancer."
Nantes, France WebsiteONCOVITA
Oncovita is a biotech company developing a disruptive virus-derived vaccine technology to treat multiple types of cancers. Our MeasovirTM platform was developed based on the safe and highly immunogenic measles virus vaccine, a vaccine with clinically proven oncolytic potential. This technology utilizes the natural anti-cancer and immunogenic properties of this harmless vaccine, making it a versatile platform to produce effective new cancer treatments and vaccines.
Oncolytic viruses, basd on from the measles virus vaccine, for treatment of solid tumors and blood cancers Paris, France WebsiteONS (Oncology Nursing Society)
The enormous contributions that our nurse members, nurse scientists, and nurse teachers have made since our inception in 1975 has made the Oncology Nursing Society who we are today: the standards bearer of advanced cancer care. Through ONS, cancer caregivers at any point on the clinical ladder are able to advance their learning and careers, understand and contribute to oncology science and best practices, advocate for their profession, and ultimately advance our cause—to continuously improve the quality of cancer care and the lives of every nurse who provides it.
Oncology Nursing Pittsburgh, PA, United States WebsiteOPALE Carnot Institute
OPALE Carnot Institute is the healthcare industry’s preferred partner for the research and development of innovative solutions aimed at diagnosis, treatment and follow-up of patients in the field of leukemia and related diseases, the deadliest blood cancer and most frequent children's cancer.
Paris, France WebsiteOrca Bio
At Orca Bio, our mission is to transform the lives of patients through high-precision cell therapy. We are developing allogeneic T-cell immunotherapies for the treatment of high-risk blood cancers including acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and myelodysplastic syndrome (MDS). We remain focused on expanding treatment to as many patients who could benefit by advancing our pipeline in blood cancer, autoimmune diseases and beyond.
Allogeneic T-cell immunotherapies Menlo Park, CA, United States WebsiteOrion Pharma
Orion Pharma is a globally operating Nordic pharmaceutical company � a builder of well-being for over a hundred years. We draw on our century-long experience in healthcare while keeping our sights firmly set on future innovations to support you every step of your way. We develop, manufacture and market human and veterinary pharmaceuticals as well as active pharmaceutical ingredients, combining our trusted expertise with continuous innovation. Proprietary products developed by us are used to treat cancer, respiratory diseases and neurological diseases, among others.
Discovery, development and commercialization of new therapies for Oncology, Respiratory Diseases, Neurologic Diseases and other areas Espoo, Finland Website